These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21999765)

  • 1. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
    Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
    Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
    Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
    Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
    Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
    Fei B; Chi AL; Weng Y
    World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
    Crea F; Duhagon Serrat MA; Hurt EM; Thomas SB; Danesi R; Farrar WL
    Int J Cancer; 2011 Apr; 128(8):1946-54. PubMed ID: 20568112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
    Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
    Jacquemin G; Granci V; Gallouet AS; Lalaoui N; Morlé A; Iessi E; Morizot A; Garrido C; Guillaudeux T; Micheau O
    Haematologica; 2012 Jan; 97(1):38-46. PubMed ID: 21933852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
    Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
    Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
    Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
    PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.
    Li J; Gong LY; Song LB; Jiang LL; Liu LP; Wu J; Yuan J; Cai JC; He M; Wang L; Zeng M; Cheng SY; Li M
    Am J Pathol; 2010 Feb; 176(2):699-709. PubMed ID: 20035051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane-Induced Death by AS101 via Inhibition of the VLA-4-IL10-Survivin Axis.
    Danoch H; Kalechman Y; Albeck M; Longo DL; Sredni B
    Mol Cancer Res; 2015 Mar; 13(3):411-22. PubMed ID: 25351768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
    Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
    BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
    Kurosu T; Fukuda T; Miki T; Miura O
    Oncogene; 2003 Jul; 22(29):4459-68. PubMed ID: 12881702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
    Faversani A; Vaira V; Moro GP; Tosi D; Lopergolo A; Schultz DC; Rivadeneira D; Altieri DC; Bosari S
    Breast Cancer Res; 2014 May; 16(3):R55. PubMed ID: 24886669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.